{"log_id": 2668843938024865258, "direction": 0, "words_result_num": 34, "words_result": [{"probability": {"variance": 0, "average": 0.889172, "min": 0.889172}, "location": {"width": 43, "top": 14, "height": 24, "left": 1176}, "words": "1"}, {"probability": {"variance": 0.066881, "average": 0.741298, "min": 0.482685}, "location": {"width": 55, "top": 49, "height": 29, "left": 1181}, "words": "证明"}, {"probability": {"variance": 0, "average": 0.999895, "min": 0.99986}, "location": {"width": 96, "top": 154, "height": 27, "left": 207}, "words": "不良反应"}, {"probability": {"variance": 1e-06, "average": 0.9993, "min": 0.997227}, "location": {"width": 183, "top": 202, "height": 29, "left": 202}, "words": "成年患者不良反应"}, {"probability": {"variance": 9e-06, "average": 0.99885, "min": 0.981277}, "location": {"width": 812, "top": 240, "height": 42, "left": 245}, "words": "在2680名类风湿关节炎患者中开展的双盲和开放性试验中对本品进行了研究。该"}, {"probability": {"variance": 0.002516, "average": 0.98935, "min": 0.680839}, "location": {"width": 858, "top": 290, "height": 44, "left": 197}, "words": "研究包括2项安慰剂对照试验(349名依那西普组患者和152名安慰剂组患者)和2项活"}, {"probability": {"variance": 8.6e-05, "average": 0.996534, "min": 0.946123}, "location": {"width": 857, "top": 341, "height": 42, "left": 200}, "words": "性对照试验,其中一项为比较依那西普和甲氨蝶呤的活性对照试验(415名依那西普组患"}, {"probability": {"variance": 0.000878, "average": 0.992701, "min": 0.804757}, "location": {"width": 859, "top": 392, "height": 41, "left": 199}, "words": "者和217名甲氨蝶呤组患者),另一项为比较依那西普(223名患者)、甲氨蝶呤(228"}, {"probability": {"variance": 9.8e-05, "average": 0.995691, "min": 0.945802}, "location": {"width": 857, "top": 440, "height": 43, "left": 200}, "words": "名患者)以及依那西普联用甲氨蝶呤(231名患者)的试验。在依那西普治疗组和安慰"}, {"probability": {"variance": 8e-06, "average": 0.998925, "min": 0.985272}, "location": {"width": 859, "top": 490, "height": 41, "left": 198}, "words": "剂治疗组中,由于不良反应而终止治疗的患者比例相同;在第一个活性对照试验中,甲"}, {"probability": {"variance": 0.002809, "average": 0.98594, "min": 0.67195}, "location": {"width": 862, "top": 539, "height": 42, "left": 197}, "words": "氨蝶呤组的退出率(10%)明显高于依那西普组(5%);在第2个活性对照试验中,经过2"}, {"probability": {"variance": 3e-06, "average": 0.999117, "min": 0.992487}, "location": {"width": 862, "top": 588, "height": 42, "left": 197}, "words": "年治疗以后3个治疗组由于不良反应退出试验的发生率相似,其中依那西普治疗组为"}, {"probability": {"variance": 0.0012, "average": 0.987665, "min": 0.839593}, "location": {"width": 862, "top": 638, "height": 42, "left": 197}, "words": "16%、甲氨蝶呤治疗组为21%、依那西普联合甲氨蝶呤治疗组为17%。在4项双盲安慰"}, {"probability": {"variance": 2e-05, "average": 0.998163, "min": 0.975931}, "location": {"width": 647, "top": 691, "height": 36, "left": 197}, "words": "剂对照的研究中,508名强直性脊柱炎患者使用本品进行了治疗。"}, {"probability": {"variance": 2e-06, "average": 0.999082, "min": 0.993676}, "location": {"width": 817, "top": 736, "height": 40, "left": 242}, "words": "在比较本品和安慰剂的双盲临床试验中,注射部位反应是本品治疗患者的最常见不"}, {"probability": {"variance": 1e-06, "average": 0.999225, "min": 0.993653}, "location": {"width": 861, "top": 786, "height": 39, "left": 198}, "words": "良反应。在类风湿关节炎患者中进行了安慰剂对照试验,依那西普治疗组349名患者和"}, {"probability": {"variance": 0.00022, "average": 0.996637, "min": 0.905815}, "location": {"width": 863, "top": 834, "height": 40, "left": 196}, "words": "安慰剂治疗组152名患者严重不良反应的发生率分别为4%和5%。在第一个活性对照"}, {"probability": {"variance": 6e-06, "average": 0.998896, "min": 0.987138}, "location": {"width": 862, "top": 883, "height": 40, "left": 197}, "words": "试验中,415名依那西普治疗患者和217名甲氨蝶呤治疗患者的严重不良反应发生率分"}, {"probability": {"variance": 9.2e-05, "average": 0.996923, "min": 0.944235}, "location": {"width": 864, "top": 931, "height": 42, "left": 195}, "words": "别为6%和8%;在第二个活性对照试验中,经过2年治疗后3个治疗组发生严重不良"}, {"probability": {"variance": 2.1e-05, "average": 0.99791, "min": 0.975888}, "location": {"width": 866, "top": 982, "height": 38, "left": 196}, "words": "事件的发生率分别为依那西普治疗组16%、甲氨蝶呤治疗组15%、依那西普联合甲氨蝶"}, {"probability": {"variance": 1.7e-05, "average": 0.996741, "min": 0.98851}, "location": {"width": 148, "top": 1040, "height": 26, "left": 193}, "words": "呤治疗组17%"}, {"probability": {"variance": 3e-06, "average": 0.998671, "min": 0.993461}, "location": {"width": 667, "top": 1079, "height": 37, "left": 242}, "words": "下述不良反应是基于在成人进行的临床试验报告和上市后监测报告"}, {"probability": {"variance": 0.000186, "average": 0.995974, "min": 0.917047}, "location": {"width": 824, "top": 1126, "height": 38, "left": 238}, "words": "在各器官系统中,将不良反应按发生率可能出现该不良反应的患者数)高低分类列"}, {"probability": {"variance": 0.000583, "average": 0.990622, "min": 0.866465}, "location": {"width": 866, "top": 1175, "height": 40, "left": 193}, "words": "出,分类标准如下:很常见(>1/10);常见(>1/100,<1/10);少见(>1/1000,<1/"}, {"probability": {"variance": 0.005085, "average": 0.968545, "min": 0.599639}, "location": {"width": 866, "top": 1223, "height": 41, "left": 197}, "words": "100)罕见(>1/10000<1/1000);非常罕见(<1/10000;未知:(临床试验中不能"}, {"probability": {"variance": 3.6e-05, "average": 0.996767, "min": 0.981232}, "location": {"width": 181, "top": 1282, "height": 29, "left": 192}, "words": "准确评估发生率)"}, {"probability": {"variance": 2.3e-05, "average": 0.997785, "min": 0.979457}, "location": {"width": 369, "top": 1375, "height": 33, "left": 193}, "words": "良性肿瘤,恶性和不明的囊肿和息肉"}, {"probability": {"variance": 0, "average": 0.998931, "min": 0.998499}, "location": {"width": 50, "top": 1430, "height": 25, "left": 191}, "words": "少见"}, {"probability": {"variance": 0, "average": 0.999321, "min": 0.997888}, "location": {"width": 189, "top": 1425, "height": 29, "left": 354}, "words": "非黑色素瘤皮肤癌"}, {"probability": {"variance": 0, "average": 0.999774, "min": 0.999411}, "location": {"width": 118, "top": 1528, "height": 28, "left": 191}, "words": "感染和侵染"}, {"probability": {"variance": 0, "average": 0.999772, "min": 0.999543}, "location": {"width": 72, "top": 1577, "height": 27, "left": 190}, "words": "很常见"}, {"probability": {"variance": 0.000166, "average": 0.996808, "min": 0.932439}, "location": {"width": 583, "top": 1569, "height": 35, "left": 352}, "words": "感染(包括上呼吸道感染、支气管炎、膀胱炎、皮肤感染)"}, {"probability": {"variance": 5.3e-05, "average": 0.994312, "min": 0.97417}, "location": {"width": 172, "top": 1625, "height": 25, "left": 190}, "words": "版本号:20090118"}, {"probability": {"variance": 2e-06, "average": 0.998546, "min": 0.995938}, "location": {"width": 169, "top": 1616, "height": 27, "left": 812}, "words": "第4页共31页"}], "language": 3}